NNVC on Alert: FDA Validation and Outperform Rating! Noble Capital sets $6 price target as broad-spectrum antiviral advances. …
Toronto Kicks Off; The Clock Is Ticking on the New '60 Minutes'; 'Ransom Canyon' Canceled by Netflix; 'NAZA' Review …
